TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹2,088 Cr | ₹2,224 Cr | ₹2,823 Cr | ₹2,238 Cr | ₹2,924 Cr |
What is the latest Total Non-Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹2,088 Cr |
| Mar2024 | ₹2,224 Cr |
| Mar2023 | ₹2,823 Cr |
| Mar2022 | ₹2,238 Cr |
| Mar2021 | ₹2,924 Cr |
How is Total Non-Current Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,088 Cr | -6.13 | |
| Mar2024 | ₹2,224 Cr | -21.21 | |
| Mar2023 | ₹2,823 Cr | 26.12 | |
| Mar2022 | ₹2,238 Cr | -23.46 | |
| Mar2021 | ₹2,924 Cr | - | |
Compare Total Non-Current Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹145,232.8 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
| MANKIND PHARMA | ₹86,793.0 Cr | -4.8% | 1% | -4.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -3.4% |
0.7% |
39.1% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses